Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27


Polymorphisms in the XPC gene and gastric cancer susceptibility in a Southern Chinese population.

Hua RX, Zhuo ZJ, Shen GP, Zhu J, Zhang SD, Xue WQ, Li XZ, Zhang PF, He J, Jia WH.

Onco Targets Ther. 2016 Sep 7;9:5513-9. doi: 10.2147/OTT.S113055.


Association of potentially functional variants in the XPG gene with neuroblastoma risk in a Chinese population.

He J, Wang F, Zhu J, Zhang R, Yang T, Zou Y, Xia H.

J Cell Mol Med. 2016 Aug;20(8):1481-90. doi: 10.1111/jcmm.12836.


Association between XPG polymorphisms and stomach cancer susceptibility in a Chinese population.

Chen YZ, Guo F, Sun HW, Kong HR, Dai SJ, Huang SH, Zhu WW, Yang WJ, Zhou MT.

J Cell Mol Med. 2016 May;20(5):903-8. doi: 10.1111/jcmm.12773.


Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome.

Chaudhary SC, Tang X, Arumugam A, Li C, Srivastava RK, Weng Z, Xu J, Zhang X, Kim AL, McKay K, Elmets CA, Kopelovich L, Bickers DR, Athar M.

Oncotarget. 2015 Nov 3;6(34):36789-814. doi: 10.18632/oncotarget.5103.


Structural insights into the recognition of cisplatin and AAF-dG lesion by Rad14 (XPA).

Koch SC, Kuper J, Gasteiger KL, Simon N, Strasser R, Eisen D, Geiger S, Schneider S, Kisker C, Carell T.

Proc Natl Acad Sci U S A. 2015 Jul 7;112(27):8272-7. doi: 10.1073/pnas.1508509112.


Development of cancer-initiating cells and immortalized cells with genomic instability.

Yoshioka K, Atsumi Y, Nakagama H, Teraoka H.

World J Stem Cells. 2015 Mar 26;7(2):483-9. doi: 10.4252/wjsc.v7.i2.483. Review.


Regulation and disregulation of mammalian nucleotide excision repair: a pathway to nongermline breast carcinogenesis.

Latimer JJ, Majekwana VJ, Pabón-Padín YR, Pimpley MR, Grant SG.

Photochem Photobiol. 2015 Mar-Apr;91(2):493-500. doi: 10.1111/php.12387.


Association between the XPG Asp1104His and XPF Arg415Gln polymorphisms and risk of cancer: a meta-analysis.

He XF, Liu LR, Wei W, Liu Y, Su J, Wang SL, Shen XL, Yang XB.

PLoS One. 2014 May 6;9(5):e88490. doi: 10.1371/journal.pone.0088490.


DNA repair diseases: What do they tell us about cancer and aging?

Menck CF, Munford V.

Genet Mol Biol. 2014 Mar;37(1 Suppl):220-33. Review.


XPG is a novel biomarker of clinical outcome in advanced non-small-cell lung cancer.

Yuli Y, Zhe S, Xia W, Siqing L, Zhenxuan W, Yu-Hua Z, Bing S, Jun-Wei C.

Pak J Med Sci. 2013 May;29(3):762-7.


High-resolution characterization of CPD hotspot formation in human fibroblasts.

Zavala AG, Morris RT, Wyrick JJ, Smerdon MJ.

Nucleic Acids Res. 2014 Jan;42(2):893-905. doi: 10.1093/nar/gkt912.


Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population.

Yang Z, Fang X, Pei X, Li H.

Genet Test Mol Biomarkers. 2013 Sep;17(9):700-6. doi: 10.1089/gtmb.2013.0122.


Molecular epidemiology of DNA repair gene polymorphisms and head and neck cancer.

Wang M, Chu H, Zhang Z, Wei Q.

J Biomed Res. 2013 May;27(3):179-92. doi: 10.7555/JBR.27.20130034.


Role of genetic heterogeneity and epistasis in bladder cancer susceptibility and outcome: a learning classifier system approach.

Urbanowicz RJ, Andrew AS, Karagas MR, Moore JH.

J Am Med Inform Assoc. 2013 Jul-Aug;20(4):603-12. doi: 10.1136/amiajnl-2012-001574.


Does melanoma begin in a melanocyte stem cell?

Hoerter JD, Bradley P, Casillas A, Chambers D, Weiswasser B, Clements L, Gilbert S, Jiao A.

J Skin Cancer. 2012;2012:571087. doi: 10.1155/2012/571087.


Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population.

He J, Xu Y, Qiu LX, Li J, Zhou XY, Sun MH, Wang JC, Yang YJ, Jin L, Wei QY, Wang Y.

PLoS One. 2012;7(11):e49308. doi: 10.1371/journal.pone.0049308.


Impact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancer.

Mi Y, Zhang L, Feng N, Wu S, You X, Shao H, Dai F, Peng T, Qin F, Zou J, Zhu L.

PLoS One. 2012;7(9):e44756. doi: 10.1371/journal.pone.0044756.


A population-based study of DNA repair gene variants in relation to non-melanoma skin cancer as a marker of a cancer-prone phenotype.

Ruczinski I, Jorgensen TJ, Shugart YY, Schaad YB, Kessing B, Hoffman-Bolton J, Helzlsouer KJ, Kao WH, Wheless L, Francis L, Alani RM, Strickland PT, Smith MW, Alberg AJ.

Carcinogenesis. 2012 Sep;33(9):1692-8. doi: 10.1093/carcin/bgs170.

Items per page

Supplemental Content

Support Center